Document is current
Any future updates will be listed below
-
Authors
Zehra, Binte
Mohamed, Nesrin
Tambi, Richa
Faizan, Muhammad
Satsangi, Dharana
Giddey, Alexander D.
Bru-Mercier, Gilles https://orcid.org/0000-0001-9794-9295
Farhat, Ahmad
Al-Jezawi, Nesreen K.
Kumail, Muhammad
Nassir, Nasna
Balan, Bipin
Kosaji, Noor
Eldesouky, Mariam
Al Yazeedi, Talal
BinEshaq, Shuhd
Shiyas, Suhana
Vinod, Nidhina
Alqassim, Saif S.
Ahmed, Awab
Hashmi, Mohammad Amiruddin
Soares, Nelson C.
Woodbury-Smith, Marc
Du Plessis, Stefan S.
Stavropoulos, Dimitri J.
Scherer, Stephen W. https://orcid.org/0000-0002-8326-1999
Alsheikh-Ali, Alawi
Khalil, Reem
Pessia, Mauro
D’Adamo, Maria Cristina
Berdiev, Bakhrom K.
Uddin, Mohammed https://orcid.org/0000-0001-6867-5803
- License Information
-
More Information
Article History
Received: 18 August 2025
Revised: 21 July 2026
Accepted: 5 August 2026
First Online: 15 August 2026
Ethics
Competing interests: The authors declare no competing interests.
Ethics: Not applicable. This study used commercially available human induced pluripotent stem cells (iPSCs) obtained from Gibco (Life Technologies). No human participants, patient-derived materials, or animal subjects were involved.
